Sign in
SIGY Stock Price, Chart, Stats & News
Sigyn Therapeutics, Inc.
Save
Sigyn Therapeutics, Inc. (SIGY) does not currently pay a dividend.
40,135
Market cap
–
Current P/E
–
Forward P/E
SIGY chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise currently in its development phase. The company's core innovation is Sigyn Therapy, an advanced blood purification system designed to overcome the limitations of existing drugs and medical devices used to treat severe inflammatory disorders. A key focus is on sepsis, which represents a major cause of hospital-related deaths.
Similar securities
Based on sector and market capitalization
Report issue